人工智能胸部X光解决方案提升ICU和ER护理途径
Pneumothorax (PTX), a condition where air collects in the pleural space and causes lung collapse, and pleura effusion (PE) in which fluid accumulates in the pleural cavity, create serious challenges in emergency rooms and intensive care units (ICUs). Now, an AI-enabled chest X-ray solution has received 510(k) FDA clearance to triage PTX and PE..
气胸（PTX）是一种空气在胸膜腔内聚集并导致肺部塌陷的疾病，胸腔积液（PE）在胸腔内积聚，对急诊室和重症监护病房（ICU）构成严峻挑战。现在，启用AI的胸部X光解决方案已获得510（k）FDA批准，以对PTX和PE进行分类。。
Qure.ai (Mumbai, MH, India) has secured 510(k) FDA clearance for its artificial intelligence-powered chest X-ray solution, known as qXR, specifically for the rapid identification of PTX and PE. This new clearance adds to the company's existing FDA-approved product range, which includes solutions like qXR-BT for breathing tube positioning, qER for emergency room head CT scans, and qER-Quant for head CT quantification software.
Qure.ai（孟买，MH，印度）已获得510（k）FDA批准，用于其人工智能胸部X光解决方案，称为qXR，专门用于快速识别PTX和PE。这一新的许可增加了该公司现有的FDA批准的产品范围，其中包括qXR BT等呼吸管定位解决方案，qER用于急诊室头部CT扫描，和qER Quant用于头部CT定量软件。
qXR is designed to integrate seamlessly into current healthcare pathways, enhancing both ICU and ER operational efficiency. Clinical evaluations of qXR's effectiveness in identifying PTX have demonstrated outstanding accuracy in providing rapid passive notifications that take an average of just 10 seconds to reach healthcare staff..
qXR旨在无缝集成到当前的医疗保健途径中，提高ICU和ER的运营效率。qXR在识别PTX方面的有效性的临床评估已经证明在提供快速被动通知方面具有出色的准确性，平均需要10秒才能到达医务人员。。
Such rapid alerting capabilities make qXR-PTX-PE an invaluable asset for timely medical decision-making, particularly in critical settings like ICUs and emergency departments. The technology employs a training dataset gathered from multiple global sources and fits seamlessly into the current standard healthcare protocols, acting as a passive notification system for prioritizing tasks.
这种快速的警报功能使qXR-PTX-PE成为及时医疗决策的宝贵资产，特别是在重症监护病房和急诊室等关键环境中。该技术采用从多个全球来源收集的训练数据集，无缝地融入当前的标准医疗协议，作为优先考虑任务的被动通知系统。
A multi-center study assessing overlooked and incorrectly labeled chest X-ray findings for conditions like PTX and PE showed that the qXR algorithm achieved up to 96% sensitivity and 100% specificity..
一项多中心研究评估了PTX和PE等疾病被忽视和错误标记的胸部X线检查结果，结果显示qXR算法的灵敏度高达96%，特异性高达100%。。
“Speaking to physicians and hospital CEOs, we have heard the increasing need to reduce time to diagnosis.' said Prashant Warier, CEO and Co-Founder of Qure. The FDA clearance of the qXR algorithm further demonstrates Qure’s commitment to addressing these challenges by optimizing healthcare delivery in time-sensitive settings like the ICU and ER.”.
“与医生和医院首席执行官交谈，我们听说越来越需要缩短诊断时间。”Qure首席执行官兼联合创始人Prashant Warier说，FDA批准qXR算法进一步证明了Qure致力于通过在ICU和ER等时间敏感的环境中优化医疗服务来应对这些挑战“。
IMRT Thorax PhantomCIRS Model 002LFC
IMRT Thorax Phantom CIRS型号002LFC
Conductive GelTensive
导电凝胶张力
Advanced Radiotherapy SystemuRT-linac 306
先进的放射治疗系统uRT linac 306
Bladder ScannerZ5 Bladder Scanner
膀胱扫描仪Z5膀胱扫描仪
相关知识
智能职工健康管理系统，提升工作效率的新途径
情绪智力培养：提升情绪管理能力的途径
基于人工智能的全方位健康解决方案
智能健康解决方案
智慧门店解决方案
智能婴儿监护解决方案
健康管理解决方案
弥合医疗保健公平差距：人工智能伦理和包容性健康解决方案
智慧养老解决方案
健康智能小屋解决方案
网址: 人工智能胸部X光解决方案提升ICU和ER护理途径 https://m.trfsz.com/newsview918915.html
